Chronic Fatigue Syndrome Among Physicians: A Potential Result of Occupational Exposure to Stealth Viruses (Part II)

Continued from Part I Case 3: In 1983, a 38-year old medical oncologist was exposed to hematemesis and bloody diarrhea from an elderly patient with persistent thrombocytopenia, splenomegaly and progressive cirrhotic liver disease. The patient showed elevated liver enzymes, but remarkably normal bilirubin until shortly before her death. Among other investigations, the elderly patient was […]

Chronic Fatigue Syndrome Among Physicians: A Potential Result of Occupational Exposure to Stealth Viruses (Part I)

Abstract Four physicians with complex chronic disabling illnesses labeled as chronic fatigue syndrome (CFS) were shown by culture to be stealth virus infected. The clinical histories indicate multi-system stealth virus infection with encephalopathy (MSVIE). The exposure of physicians and other health care providers to stealth viruses is a potential occupational hazard.

Chemokines and Stealth Viruses:A Blueprint for Therapy in Infected Humans and Animals (Part II)

Continued from Part I Partial Listing of Agents Known to Influence Chemokine Production and Activities The accompanying table is intended to illustrate the vast number of agents that have been reported to influence the production and/or activities of CC and CXC chemokines. The cytokine NF-kB is a potent stimulus to chemokine production. NF-kB is normally […]

Chemokines and Stealth Viruses: A Blueprint for Therapy in Infected Humans and Animals (Part I)

Chemokines: Relatively small proteins (peptides) that mediate intercellular signaling among lymphocytes responding to antigenic challenge, were originally referred to as lymphokines. This term was replaced by interleukins, since lymphokine did not fully reflect intercellular communications between lymphocytes and cells of macrophage/monocyte lineage. It was further realized that related, and sometimes even identical peptides, were being […]

  •